Statera Biopharma, Inc. Quarterly Goodwill in USD from Q4 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Statera Biopharma, Inc. quarterly Goodwill history and growth rate from Q4 2020 to Q3 2022.
  • Statera Biopharma, Inc. Goodwill for the quarter ending September 30, 2022 was $9.27M, a 88% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $9.27M -$67.7M -88% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $9.27M Jun 30, 2022 10-Q 2022-10-28
Q1 2022 $9.27M Mar 31, 2022 10-Q 2022-10-21
Q4 2021 $9.27M +$9.27M Dec 31, 2021 10-Q 2022-11-14
Q3 2021 $77M Sep 30, 2021 10-Q 2021-11-15
Q4 2020 $0 Dec 31, 2020 10-K 2022-10-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.